Table 2.
No | Triggers | Positive Triggers | ADEs † | PPV ‡ (%) |
---|---|---|---|---|
Laboratory Index | ||||
L1 | Partial thromboplastin time (PTT) > 100 s1,9,23 | 23 | 4 | 17.4 |
L2 | International normalized ratio (INR) > 3.51,20 | 2 | 1 | 50.0 |
L3 | Hypoglycaemia (≤2.8 mmol.L−1)20 | 13 | 5 | 38.5 |
L4 | Hyperglycaemia (≥7.8 mmol.L−1)12,20 | 40 | 5 | 12.5 |
L5 | Rising urea or creatinine (>2 × baseline)12 | 3 | 0 | 0 |
L6 | Rising alanine aminotransferase or aspartate transaminase or total bilirubin and alkaline phosphatase (>2 × baseline)1 | 115 | 14 | 12.2 |
L7 | Hypokalemia (<3 mmol.L−1)1,12 | 32 | 6 | 18.8 |
L8 | Hyperkalemia (>5.5 mmol.L−1)1,20 | 89 | 1 | 1.1 |
L9 | Hyponatremia (<130 mmol.L−1)1,12,20 | 12 | 1 | 8.3 |
L10 | Leukocyte count < 3*109.L−123,24 | 13 | 3 | 23.1 |
L11 | Platelets count < 50*109.L−112 | 0 | 0 | 0 |
L12 | Elevated drug levels: Vancomycin > 30 mg.L−1\ Amikacin > 5 mg.L−11,20 | 0 | 0 | 0 |
L13 | Phenytoin > 40 mg.L−1\ Valproic acid > 150 mg.L−1\Phenobarbital > 50 mg.L−1\Carbamazepine > 15 mg.L−1\Clonazepam > 80 µg.L−1\Nitrazepam > 200 µg.L−1\Oxcarbazepine > 35 mg.L−1\Phenobarbital > 20 mg.L−1[20] | 0 | 0 | 0 |
L14 | Cyclosporin A > 400 µg.L−1 (treatment)\> 500 µg.L−1 (transplantation of organ) | 0 | 0 | 0 |
L15 | Elevated drug levels: Digoxin > 2 µg.L−1 1,23 | 0 | 0 | 0 |
L16 | Elevated drug levels: Lidocaine > 5 mg.L−1 23 | 0 | 0 | 0 |
L17 | Elevated drug levels: Theophylline > 20 g.L−1 1,23 | 0 | 0 | 0 |
Antidotes | ||||
A1 | Anti-allergic or Adrenaline use6 | 312 | 21 | 6.8 |
A2 | Flumazenil use6 | 45 | 40 | 88.9 |
A3 | Naloxone\Nalmefene use6 | 54 | 23 | 42.6 |
A4 | Anti-emetic use6 | 303 | 21 | 6.9 |
A5 | Ongoing or intermittent laxative use20 | 321 | 20 | 6.2 |
A6 | Protamine use20 | 16 | 2 | 12.5 |
A7 | Antidiarrheal or Antidiarrheal administration23 | 364 | 35 | 9.6 |
A8 | Glutathione use | 161 | 16 | 9.9 |
A9 | Nystatin and Sodium bicarbonate use | 25 | 25 | 100 |
Clinical Symptoms | ||||
S1 | Over sedation\hypotension\falls9 | 6 | 2 | 33.3 |
S2 | Rash9,24 | 285 | 35 | 12.3 |
Intervention Measures | ||||
T1 | Abrupt medication stop6 | 15 | 13 | 86.7 |
T2 | Transfer to higher level of care10,20 | 15 | 4 | 26.7 |
T3 | Rescue20 | 27 | 7 | 25.9 |
Total | 2291 | 304 | 13.3 |
†ADEs, Adverse drug events; it indicates the number of adverse drug events detected by triggers, and different triggers in a patient can indicate same adverse drug events.
‡PPV, Positive predictive value; it indicates the percentage of triggers that predict ADEs.